ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,460,208, issued on Nov. 4, was assigned to PARR BIOTECHNOLOGY Co. LTD. (Shijiazhuang, China).
"Immunomodulatory polynucleotides and uses thereof" was invented by Yan Shao (Changchun, China) and Li-Gong Wang (Changchun, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compositions comprising immunomodulatory polynucleotides as therapeutics, such as for immunotherapy. Further, the present invention relates to the use of the compositions in the treatment of diseases such as cancers."
The patent was filed on May 6, 2022, under Application No. 17/662,392.
*For further information, including images, charts and tables, ple...